although
equin
infecti
anemia
eia
recogn
infecti
viral
diseas
hors
equida
sinc
earli
effect
treatment
vaccin
current
avail
infect
hors
remain
infect
life
often
without
show
recogniz
clinic
sign
major
research
effort
aim
develop
accur
diagnost
test
earli
dr
leroy
coggin
develop
su
h
test
known
veterinarian
hors
owner
coggin
test
test
becam
basi
widespread
feder
state
regul
aim
elimin
carrier
viru
research
eia
slow
scientist
recogn
close
relationship
eia
viru
eia
v
human
immunodefici
virus
hiv
led
renew
research
pathogenesi
eia
mani
new
discoveri
viru
diseas
etiolog
agent
eia
eia
v
offici
classifi
subfamili
lentivirina
famili
retrovirida
base
genet
revers
transcriptas
serolog
crossreact
close
relat
lentivirus
includ
caprin
arthritisenceph
viru
visnamaedi
viru
sheep
human
felin
immunodefici
virus
eia
v
envelop
rna
viru
cover
surfac
knob
contain
dens
conic
shape
core
fig
exterior
lipid
envelop
viru
deriv
host
cell
plasma
membran
particl
matur
surfac
knob
virusspecif
glycoprotein
probabl
requir
viru
penetr
host
cell
act
potent
immunostimul
emerg
host
novel
antigen
variant
surfac
glycoprotein
result
recrudesc
febril
reaction
characterist
diseas
viru
dens
central
core
consist
viral
rna
four
nonglycosyl
structur
nucleocapsid
viral
revers
transcriptas
enzym
viral
rna
genom
encod
three
major
product
group
design
gag
groupassoci
antigen
code
major
intern
structur
protein
pol
polymeras
design
revers
transcriptas
enzym
ribonucleas
h
dnanick
enzym
aid
integr
host
cell
genom
env
envelop
produc
envelop
glycoprotein
addit
three
short
segment
rna
probabl
code
smaller
viral
regulatori
protein
nonglycosyl
structur
core
protein
less
prone
antigen
variat
surfac
glycoprotein
abund
core
protein
consist
evok
strong
humor
immun
respons
infect
hors
use
basi
serolog
diagnost
test
viru
revers
transcriptas
enzym
uniqu
retrovirus
catalyz
convers
viral
rna
genom
dna
complementari
dna
cdna
insert
host
chromosom
dna
effect
hide
host
defens
mechan
persist
hors
rest
life
hors
infect
eia
v
may
present
acut
syndrom
high
fever
thrombocytopenia
andor
anemia
subacut
chronic
syndrom
recrudesc
fever
weight
loss
ventral
edema
sever
anemia
may
appear
clinic
normal
specif
clinic
sign
hors
show
follow
infect
depend
factor
strain
viru
involv
dose
viru
hors
receiv
individu
host
respons
viru
hors
infect
highli
virul
strain
eia
v
may
present
fever
sever
thrombocytopenia
depress
anorexia
mild
moder
anemia
within
day
initi
infect
sever
affect
hors
develop
epistaxi
ventral
pit
edema
die
primari
responsey
titer
infecti
viru
serum
infect
hors
increas
increas
viral
antigen
detect
almost
tissu
highest
titer
found
serum
liver
spleen
lymph
node
bone
marrow
lung
kidney
major
viral
replic
febril
episod
appear
occur
matur
tissu
macrophag
tissu
circul
blood
monocyt
hors
spontan
recov
initi
virem
episod
period
sever
day
appear
clinic
normal
variabl
period
time
day
week
experi
recur
episod
fever
thrombocytopenia
depress
febril
episod
associ
viremia
resolv
coincid
resolut
fever
febril
episod
circul
viru
highli
cellassoci
free
plasma
frequenc
sever
febril
episod
declin
time
clinic
episod
occur
first
month
mani
hors
eventu
ceas
clinic
episod
fever
viremia
becom
inappar
carrier
viru
hors
progress
chronic
debilit
form
diseas
classic
clinic
sign
weight
loss
anemia
edema
eventu
death
eiavseroposit
hors
appear
healthi
owner
frequent
report
never
notic
clinic
sign
diseas
like
hors
infect
less
virul
strain
viru
lower
titer
inoculum
experi
mild
febril
thrombocytopen
episod
could
easili
pass
undetect
observ
owner
diagnosi
made
difficult
earli
infect
hors
may
seroneg
day
postinfect
despit
fact
hors
show
recogniz
clinic
sign
continu
harbor
viru
serv
reservoir
infect
remaind
life
risk
uninfect
hors
contact
administr
immunosuppress
drug
dexamethason
often
precipit
viral
replic
clinic
diseas
hors
occasion
eiavinfect
hors
show
neurolog
abnorm
without
exhibit
clinic
sign
eia
antieia
v
antibodi
may
detect
agar
gel
immunodiffus
acid
cerebrospin
fluid
hors
neurolog
transmiss
eiav
transmit
infect
uninfect
hors
transfer
blood
blood
product
commonli
occur
interrupt
feed
larg
hematophag
insect
especi
famili
tabanida
horsefli
deerfli
transmiss
may
also
occur
iatrogen
administr
contamin
blood
transfus
use
contamin
hypoderm
needl
use
nonsteril
contamin
surgic
instrument
includ
teeth
float
transplacent
colostr
transmiss
also
loo
eia
v
transmit
interrupt
feed
singl
factor
influenc
effici
transmiss
includ
avail
appropri
vector
distanc
hors
viru
titer
blood
infect
hors
tabanid
like
transmit
viru
mosquito
two
reason
larg
mouthpart
tabanid
capabl
carri
much
larger
quantiti
blood
nl
small
mouthpart
mosquito
addit
larg
mouthpart
inflict
much
pain
bite
smaller
insect
fli
act
mechan
vector
transmiss
eia
v
viru
live
long
mouthpart
insect
minut
hour
effect
transmiss
viru
requir
fli
begin
feed
infect
hors
interrupt
immedi
fli
uninfect
hors
resum
feed
larg
mouthpart
horsefli
deerfli
inflict
pain
bite
hors
like
interrupt
tail
swish
bite
bodi
movement
fli
interrupt
middl
blood
meal
immedi
seek
complet
meal
rebit
initi
host
bite
nearbi
anim
flight
rang
horsefli
exceed
fli
seek
complet
meal
rapidli
possibl
nearest
hors
initi
host
separ
anim
distanc
yard
fli
much
like
resum
feed
origin
host
fli
distanc
requir
find
new
host
consider
form
basi
mani
state
eia
v
regulatori
decis
acut
infect
hors
undergo
febril
reaction
higher
plasma
viru
titer
infect
afebril
hors
factor
therefor
greater
probabl
viru
transmiss
febril
hors
hors
clinic
sign
clinic
ill
hors
probabl
serv
major
impetu
transmiss
propag
epizoot
despit
consider
inappar
carrier
remain
virem
indefinit
sever
studi
shown
anim
remain
potenti
sourc
viru
transmiss
field
condit
viru
hors
highli
cellassoci
confin
small
percentag
circul
mononuclear
leukocyt
serolog
posit
hors
consid
reservoir
infect
potenti
infecti
anim
vener
transmiss
viru
possibl
probabl
occur
frequent
subcutan
inocul
experiment
hors
fresh
semen
eiavinfect
stallion
transmit
viru
one
mare
pastur
eiavneg
anim
seroconvert
follow
breed
chronic
infect
stallion
loo
mare
exhibit
slight
hemorrhag
vulva
breed
infect
stallion
may
reduc
fertil
evalu
semen
two
stallion
chronic
infect
eia
v
reveal
decreas
motil
reduc
sperm
count
abnorm
morpholog
featur
spermatozoa
ioo
potenti
rout
infect
mare
foal
includ
transplacent
transfer
colostr
milk
transmiss
vector
transmiss
transplacent
transmiss
eia
v
like
occur
dam
experi
acut
febril
reaction
accompani
high
titer
viremia
may
result
abort
birth
infect
foal
experiment
infect
equin
fetus
result
abort
foal
infect
day
gestat
abort
occur
day
postinfect
fetus
infect
later
gestat
foal
born
seroposit
die
within
day
experiment
less
foal
born
mare
clinic
sign
eia
gestat
born
virusand
antibodyposit
uninfect
foal
nurs
colostrum
infect
mare
absorb
antieia
v
colostr
antibodi
loo
colostr
antibodi
gener
undetect
month
age
evid
viru
may
transmit
colostrum
milk
definit
determin
insect
preferenti
feed
adult
hors
insect
transmiss
infect
mare
uninfect
foal
appear
major
problem
one
pasturebas
studi
mare
foal
foal
tabanid
feed
occurr
compar
mare
due
foal
smaller
size
fli
like
feed
adult
poni
adult
hors
two
graze
side
side
thrombocytopenia
consist
laboratori
abnorm
detect
acut
infect
platelet
count
may
start
decreas
prior
increas
rectal
temperatur
hors
experiment
infect
virul
viru
decreas
circul
platelet
count
abnorm
note
ure
initi
virem
episod
thrombocytopenia
recur
subsequ
febril
episod
gener
persist
throughout
virem
period
may
becom
sever
enough
caus
hemorrhag
especi
epistaxi
petechi
hemorrhag
mucou
membranesi
platelet
count
usual
rebound
rapidli
fo
llow
resolut
viremiay
decreas
pack
cell
volum
total
erythrocyt
count
may
becom
evid
earli
day
postinfect
may
becom
sever
initi
febril
episod
common
howev
sever
anemia
seen
hors
undergo
multipl
febril
episod
abnorm
may
note
complet
blood
count
includ
leukopenia
leukocytosi
monocytosi
evid
vivo
activ
monocyt
macrophag
eia
v
infect
hors
monocyt
show
increas
bind
autolog
erythrocyt
exhibit
decreas
vitro
migrat
compar
monocyt
uninfect
hors
signific
monocyt
activ
investig
howev
tissu
macrophag
major
site
viral
replic
vivo
cell
also
known
remov
immun
complexco
erythrocyt
platelet
circul
infect
hors
activ
could
occur
concurr
either
activ
report
biochem
abnorm
includ
increas
serum
calcium
decreas
serum
iron
increas
serum
bilirubin
seen
signific
hemolysi
occur
erythrocyt
lactat
dehydrognas
dehydrogenas
activ
increas
anemia
develop
attribut
presenc
younger
erythrocyt
circul
febril
hors
circul
blood
sideroleukocyt
fix
bone
marrow
sideroleukocyt
phagocyt
cell
contain
aggreg
hemosiderin
secondari
ingest
sensit
erythrocyt
may
present
detect
cell
use
diagnost
test
eia
prior
widespread
use
sensit
specif
agio
test
sideroleukocyt
decreas
number
eventu
disappear
resolut
viremia
associ
clinic
nonspecif
hypergammaglobulinemia
may
present
chronic
infect
hors
necropsi
eiavinfect
hors
die
febril
episod
often
reveal
gener
lymph
node
enlarg
hepatomegali
splenomegali
accentu
hepat
lobular
structur
mucos
viscer
hemorrhag
ventral
subcutan
edema
vessel
thrombosi
histopatholog
usual
reveal
accumul
lymphocyt
macrophag
periport
area
liver
lymph
node
adren
gland
spleen
mening
lung
lymphop
rolif
lesion
may
result
spread
virusreact
tlymphocyt
attempt
control
infect
histopatholog
lesion
liver
includ
fatti
degener
hepat
cell
necrosi
kupffer
cell
frequent
swollen
may
contain
hemosiderin
aggreg
macrophag
lymph
node
spleen
bone
marrow
may
similarli
show
increas
hemosiderin
deposit
hemorrhag
edema
attribut
vascular
chang
especi
vascular
mesenchym
tissu
necropsi
eia
v
infect
hors
die
appar
clinic
sign
diseas
frequent
unremark
anim
may
glomerul
increas
cellular
thicken
glomerular
tuft
retin
depigment
promin
choroid
vessel
observ
eye
clinic
normal
eiavinfect
hors
histopatholog
chronic
nongranulomat
choroid
foci
lymphocyt
infiltr
present
horseslo
immunopathogenesi
immedi
infect
eia
v
replic
high
titer
primarili
matur
tissu
macrophag
liver
spleen
lymph
node
lung
kidney
adren
gland
progeni
virion
releas
circul
titer
viru
plasma
appear
parallel
increas
rectal
temperatur
presenc
high
concentr
viral
antigen
circul
tissu
stimul
host
antibodi
product
specif
antivir
antibodi
frequent
detect
western
immunoblot
earli
day
postinfectioni
day
postinfect
antibodi
core
protein
detect
acid
almost
infect
hors
mark
antibodi
respons
also
develop
extern
envelop
glycoprotein
viru
net
result
heterogen
hypergammaglobulinemia
increas
igc
igc
igm
concentr
day
postinfect
especi
hors
experi
multipl
febril
episod
resolut
serum
viremia
associ
febril
episod
depend
specif
band
tcellmedi
respons
rapid
appear
high
level
antibodi
serum
infect
hors
might
implic
involv
clearanc
viru
circul
howev
vitro
studi
demonstr
neutral
antieia
v
antibodi
direct
highli
variabl
antigen
epitop
surfac
glycoprotein
antibodi
detect
serum
infect
hors
day
week
resolut
febril
episod
impli
neutral
antibodi
probabl
import
clearanc
viru
circul
investig
feel
cellmedi
immun
respons
must
critic
involv
import
function
despit
mount
strong
humor
cellmedi
immun
respons
eiav
infect
hors
unabl
complet
clear
viru
bodi
remain
infect
life
direct
evid
viral
persist
includ
transmiss
infect
inappar
carrier
suscept
anim
transfus
wash
leukocyt
whole
blood
presenc
infecti
circul
immun
complex
induct
diseas
follow
dexamethason
administr
cellular
reservoir
eia
v
clinic
normal
hors
known
hypothes
subpopul
tissu
macrophag
eia
v
probabl
continu
replic
low
level
reservoir
cell
revers
transcriptas
eia
v
lack
proofread
capac
prone
error
copi
eiav
genom
result
high
frequenc
genet
mutat
genet
mutat
turn
result
alter
viral
epitop
enabl
new
antigen
variant
temporarili
escap
host
neutral
immun
variant
replic
high
titer
precipit
anoth
febril
episod
viral
envelop
glycoprotein
structur
variabl
viral
viru
isol
recov
sequenti
febril
episod
show
isol
structur
uniqu
variat
envelop
glycoprotein
occur
random
noncumul
process
eventu
cessat
clinic
episod
hors
may
occur
host
eventu
mount
neutral
immun
respons
epitop
common
potenti
variant
eia
v
abil
eiav
undergo
rapid
antigen
variat
vivo
may
import
viral
persist
major
obstacl
vaccin
develop
although
rapid
antigen
variat
undoubtedli
import
viral
persist
factor
also
involv
import
factor
contribut
viral
persist
probabl
abil
viru
insert
dna
copi
viral
genet
materi
host
chromosom
dna
dna
lie
dormant
long
period
time
littl
transcript
translat
viral
gene
cell
express
viral
antigen
recogn
infect
host
immun
surveil
techniqu
stimuli
respons
reactiv
dormant
viru
conclus
identifi
hors
undergo
repeat
febril
episod
diseas
associ
high
titer
viremia
stimulu
immun
system
host
immens
intensifi
prolong
inabl
immun
respons
clear
viru
bodi
result
clinic
sign
lesion
acut
chronic
diseas
attribut
host
immun
respons
viru
direct
result
viral
replic
antibodi
produc
earli
eia
v
infect
direct
conserv
epitop
surfac
glycoprotein
antibodi
nonneutr
combin
circul
viru
without
render
viru
noninfecti
consequ
viru
serum
febril
hors
exist
infecti
immun
complex
immun
complex
may
enhanc
abil
viru
enter
host
cell
probabl
involv
develop
clinic
abnorm
eia
includ
fever
depress
thrombocytopenia
anemia
glomerulonephr
macrophag
activ
phagocyt
cell
capabl
intern
materi
nonspecif
manner
fc
receptor
macrophag
may
bind
circul
infecti
immljn
complex
intern
ligand
clathrinco
pit
releas
intact
virion
core
lysosom
structur
wide
divers
viru
type
eg
dengu
hemorrhag
fever
flaviviru
infect
felin
infecti
periton
coronaviru
infect
cat
use
nonneutr
antibodi
suboptim
concentr
neutral
antibodi
enhanc
infect
suggest
may
gener
biolog
phenomenon
infecti
agent
develop
avoid
inde
exploit
host
immun
respons
poni
inocul
purifi
eia
v
glycoprotein
develop
sever
clinic
sign
challeng
virul
eia
v
poni
previous
expos
viral
antigen
may
reflect
antibodymedi
enhanc
infect
vivo
rapidli
increas
viremia
acut
infect
hors
parallel
increas
rectal
temperaturey
temperatur
high
c
may
seen
acut
infect
hors
fever
probabl
result
releas
inflammatori
cytokin
interleukin
tumor
necrosi
factor
infect
macrophag
may
increas
stimul
immun
complex
inflammatori
cytokin
also
could
incrimin
depress
decreas
appetit
observ
anim
thrombocytopenia
one
earliest
consist
hematolog
abnorm
observ
experiment
infect
natur
infect
febril
horsesi
sever
affect
anim
profound
thrombocytopenia
may
develop
contribut
petechi
mucou
membran
andor
clinic
bleed
platelet
count
return
normal
serum
viremia
resolv
thrombocytopenia
like
result
attach
infecti
immun
complex
circul
platelet
via
fc
andor
complement
receptor
may
occur
earli
day
postinfectioni
antibodyco
platelet
clear
circul
tissu
macrophag
spleen
lymph
node
hepat
kupffer
cell
thu
anoth
manifest
antibodymedi
enhanc
infect
platelet
may
serv
carrier
mechan
target
viru
form
infecti
immun
complex
host
cell
permiss
viral
replic
chronic
infect
hors
undergon
multipl
febril
episod
develop
moder
sever
anemia
viru
deriv
name
hors
sever
hightit
viremia
may
becom
anem
initi
febril
episod
uncommon
natur
condit
declin
erythrocyt
number
attribut
intravascular
extravascular
hemolysi
well
gener
depress
bone
marrow
erythropoiesi
hors
acut
eia
v
infect
erythrocyt
lifespan
vari
day
normal
day
increas
plasma
hemoglobin
concentr
decreas
plasma
haptoglobin
concentr
indic
intravascular
hemolysi
occur
hors
later
stage
diseas
erythrocyt
lifespan
vari
day
detect
chang
plasma
hemoglobin
haptoglobin
concentr
indic
extravascular
hemolysi
erythrocyt
eiavinfect
hors
coat
complement
although
antibodi
detect
igg
igm
igg
specif
direct
coomb
sensit
elut
studi
demonstr
immunoglobulin
present
low
quantiti
surfac
erythrocyt
hors
possibl
viral
hemagglutinin
activ
attribut
surfac
glycoprotein
enabl
viru
attach
circul
erythrocyt
attract
specif
altern
circul
virusantibodi
immun
complex
may
attach
erythrocyt
via
fc
complement
receptor
viru
virusantibodi
complex
adsorb
hors
erythrocyt
activ
complement
via
classic
complementmedi
intravascular
hemolysi
result
altern
extravascular
hemolysi
may
occur
complementco
erythrocyt
phagocyt
macrophagelik
cell
bone
marrow
splenic
macrophag
acut
infect
hors
contain
larg
amount
hemosiderin
cellular
debri
indic
activ
erythrophagocytosi
hemolyt
anemia
observ
hors
eia
exacerb
impair
bone
marrow
chronic
infect
hors
often
decreas
serum
iron
concentr
transferrin
satur
plasma
iron
turnov
increas
bone
marrow
myeloidtoerythroid
arabian
foal
combin
immunodefici
becom
profoundli
anem
infect
eiav
despit
inabl
mount
specif
antibodi
cellmedi
immun
respons
recent
vitro
experi
equin
bone
marrow
eia
v
confirm
abil
viru
inhibit
bone
marrow
erythropoiesi
glomerulonephr
mesangi
epitheli
cell
prolifer
basement
membran
thicken
present
approxim
eiavinfect
igg
third
compon
complement
present
small
granular
deposit
along
glomerular
basement
membran
antieia
v
antibodi
elut
isol
diseas
glomeruli
although
deposit
virusantibodycompl
immun
complex
glomeruli
appear
common
phenomenon
chronic
eia
v
infect
clinic
proteinuria
rare
diseas
diagnosi
may
begin
clinic
suspicion
base
sign
recurr
fever
thrombocytopenia
anemia
ventral
edema
weight
loss
mani
febril
virem
hors
circul
bone
marrow
sideroleukocyt
cell
consid
diagnost
eia
v
infect
prior
avail
accur
serolog
test
today
clinic
diagnosi
eia
v
confirm
one
two
laboratori
test
eiavinfect
hors
show
clinic
sign
diseas
common
eia
antibodi
detect
routin
evalu
test
appar
healthi
hors
current
two
approv
laboratori
test
diagnosi
eia
v
infect
acid
coggin
test
competit
enzymelink
immunosorb
assay
celisa
state
may
differ
test
test
approv
recogn
test
detect
antibodi
core
protein
eia
v
unlik
surfac
glycoprotein
viru
protein
subject
rapid
antigen
chang
antibodi
recogn
crossreact
viru
isol
acid
coggin
test
develop
earli
highli
sensit
specif
test
least
accur
diagnosi
eia
v
infect
remain
wide
use
laboratori
test
diagnosi
hors
seroconvert
acid
within
day
infect
coggin
test
perform
layer
agar
petri
dish
solubl
eia
v
antigen
place
central
well
agar
plate
surround
well
contain
either
posit
neg
control
sera
test
sera
solubl
reagent
diffus
radial
well
agar
establish
circular
concentr
gradient
reactant
zone
optim
proport
solubl
antigen
antieiav
antibodi
reach
opaqu
line
precipit
appear
line
precipit
form
well
contain
neg
serum
solubl
antigen
although
acid
test
consid
highli
sensit
specif
hors
identifi
consist
neg
equivoc
result
subsequ
prove
infect
eia
v
inocul
seroneg
hors
blood
suspect
hors
celisa
recent
approv
diagnosi
eiav
comparison
celisa
acid
test
result
favor
agreement
celisa
acid
test
result
one
studi
compar
equin
sera
neg
sampl
posit
sampl
borderlineposit
sampl
issei
colleagu
report
celisa
gave
posit
result
six
serum
sampl
equivoc
acid
reaction
identif
hors
equivoc
neg
acid
celisa
test
subsequ
prove
infect
hors
inocul
assay
illustr
need
sensit
confirmatori
test
hors
question
celisa
acid
test
result
may
test
virusspecif
antibodi
use
western
immunoblot
assayso
western
immunoblot
assay
simultan
detect
antibodi
surfac
glycoprotein
well
core
protein
uninfect
hors
weak
nonspecif
band
appear
posit
must
differenti
specif
antibodi
polymeras
chain
reaction
pcr
test
peripher
blood
mononuclear
cell
buffi
coat
cell
may
also
help
confirm
diagnosi
specif
primer
avail
lo
inappar
carrier
hors
circul
infect
cell
peripher
blood
test
may
result
falseneg
reaction
unit
state
feder
state
control
measur
aim
elimin
inappar
carrier
eia
v
state
requir
hors
neg
eia
v
test
within
month
travel
state
mani
state
also
requir
neg
eia
v
test
time
transfer
ownership
hors
local
hors
show
race
track
poni
club
meet
trail
ride
board
stabl
forth
also
option
requir
neg
eia
v
test
prior
particip
entri
fate
eiavposit
hors
depend
law
state
hors
test
state
offer
option
eia
v
posit
hors
includ
euthanasia
form
perman
identif
lifelong
quarantin
least
yard
equida
shipment
anim
recogn
research
facil
state
requir
tattoo
brand
mark
hors
transport
anywher
state
interst
travel
known
posit
anim
prohibit
except
hors
return
place
origin
hors
transport
slaughterhous
hors
move
diagnost
laboratori
research
facil
approv
deputi
administr
usda
anim
plant
health
inspect
servic
concurr
regulatori
offici
state
depart
agricultur
eia
v
posit
hors
transport
across
state
line
hors
must
offici
identifi
use
nation
uniform
tag
code
number
assign
usda
state
hors
test
follow
letter
identif
may
take
form
lip
tattoo
shoulder
neck
brand
brand
may
hot
iron
chemic
freezemark
must
least
inch
high
place
left
shoulder
left
side
neck
lip
tattoo
less
inch
high
inch
wide
place
inner
surfac
upper
lip
falsif
health
certif
eia
reactor
veterinarian
result
fine
andor
loss
feder
accredit
sinc
widespread
eiav
control
measur
institut
earli
incid
eia
decreas
dramat
throughout
unit
state
first
year
test
posit
hors
found
gulf
coast
state
temperatur
humid
favor
prolong
vector
season
texa
louisiana
mississippi
alabama
florida
hors
test
seroposit
contrast
hors
test
state
seroposit
percentag
seroposit
test
diminish
gulf
coast
state
respect
unit
state
map
figur
illustr
gulf
coast
region
still
greatest
number
posit
eia
test
although
absolut
number
decreas
dramat
sinc
earli
year
test
eia
v
test
report
unit
state
octob
septemb
posit
arkansa
largest
absolut
number
posit
test
highest
percent
posit
although
feder
state
control
markedli
decreas
incid
eia
unit
state
diseas
erad
outbreak
diseas
still
may
increas
area
decreas
vigil
part
hors
owner
veterinarian
other
owner
veterinarian
voluntarili
implement
varieti
control
measur
decreas
chanc
exposur
hors
infect
hors
measur
includ
requir
neg
eia
v
test
prior
purchas
hors
donkey
mule
requir
document
recent
neg
eia
test
prior
permit
entri
new
hors
premis
hors
origin
state
high
incid
eiavposit
hors
eg
gulf
coast
state
test
probabl
date
within
day
entri
farm
hors
ongmat
state
low
incid
eiavposit
hors
test
within
month
year
adequ
institut
fli
control
measur
wherev
possibl
encourag
offici
event
involv
congreg
larg
number
hors
requir
recent
neg
eia
test
hors
particip
test
hors
donkey
mule
premis
least
year
permit
inject
differ
hors
common
needl
thoroughli
disinfect
surgic
instrument
tattoo
instrument
teeth
float
use
abil
eia
v
persist
infect
hors
face
profound
immun
respons
host
make
potenti
devast
diseas
hors
popul
unit
state
abil
evad
host
immun
defens
lie
dormant
appar
healthi
anim
rapidli
chang
antigen
determin
prove
major
obstacl
vaccin
develop
infect
hors
appear
clinic
normal
larg
proport
hors
countri
remain
untest
viru
like
erad
near
futur
yet
reason
hors
infect
eiav
appear
clinic
normal
tendenc
hors
industri
becom
complac
effort
control
viru
cooper
hors
owner
veterinarian
regulatori
offici
necessari
keep
threat
eia
check
unit
state
